Credit Agricole’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$123 Hold
44
﹤0.01% 1258
2024
Q4
$764 Hold
44
﹤0.01% 1259
2024
Q3
$1.2K Hold
44
﹤0.01% 1259
2024
Q2
$1.8K Hold
44
﹤0.01% 1079
2024
Q1
$21 Sell
44
-1
-2% -$75 ﹤0.01% 946
2023
Q4
$51 Buy
+45
New +$4.7K ﹤0.01% 903
2023
Q3
Sell
-45
Closed -$16.5K 929
2023
Q2
$16.5K Hold
45
﹤0.01% 603
2023
Q1
$30K Buy
45
+42
+1,400% +$37.3K ﹤0.01% 538
2022
Q4
$2.92K Sell
3
-14
-82% -$17.6K ﹤0.01% 660
2022
Q3
$18K Hold
17
﹤0.01% 572
2022
Q2
$14K Sell
17
-47
-73% -$48.4K ﹤0.01% 588
2022
Q1
$99K Buy
64
+42
+191% +$56.7K ﹤0.01% 480
2021
Q4
$40K Hold
22
﹤0.01% 546
2021
Q3
$74K Buy
22
+2
+10% +$7K ﹤0.01% 464
2021
Q2
$87K Sell
20
-8
-29% -$31.6K ﹤0.01% 441
2021
Q1
$137K Buy
+28
New +$158K ﹤0.01% 366

Other funds holding BNGO

Credit Agricole's BNGO Position: Q1 2025 in Review

Credit Agricole held its Bionano Genomics (BNGO) position steady in Q1 2025 at 44 shares worth $123. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

Credit Agricole first reported a position in BNGO in Q1 2021 and has held it in 16 quarters since. The position peaked at $137K in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Credit Agricole held 44 shares of Bionano Genomics worth $123 as of Q1 2025.
  • Credit Agricole left its Bionano Genomics share count unchanged in Q1 2025.
  • Bionano Genomics made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1258 holding.
  • Credit Agricole first reported a position in Bionano Genomics in Q1 2021 and has held it in 16 quarters since.
  • Credit Agricole's Bionano Genomics position peaked at $137K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.